Diabetes mellitus in breast cancer survivors: metabolic effects of endocrine therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
https://www.nature.com/articles/s41574-023-00899-0.pdf
Reference144 articles.
1. World Health Organization. Breast cancer. WHO https://www.who.int/news-room/fact-sheets/detail/breast-cancer (2023).
2. Pan, H. et al. 20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. N. Engl. J. Med. 377, 1836–1846 (2017).
3. Mouridsen, H., Palshof, T., Patterson, J. & Battersby, L. Tamoxifen in advanced breast cancer. Cancer Treat. Rev. 5, 131–141 (1978).
4. Meisel, J. L., Venur, V. A., Gnant, M. & Carey, L. Evolution of targeted therapy in breast cancer: where precision medicine began. Am. Soc. Clin. Oncol. Educ. Book 38, 78–86 (2018).
5. Early Breast Cancer Trialists’ Collaborative Group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. N. Engl. J. Med. 319, 1681–1692 (1988).
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Metformin use correlated with lower risk of cardiometabolic diseases and related mortality among US cancer survivors: evidence from a nationally representative cohort study;BMC Medicine;2024-06-26
2. Triple-Negative Breast Cancer EVs Modulate Growth and Migration of Normal Epithelial Lung Cells;International Journal of Molecular Sciences;2024-05-28
3. The research trends and future prospects of nanomaterials in breast cancer;Cancer Nanotechnology;2024-04-25
4. Non-sclerosing (T-cell) and sclerosing (B-cell) lymphocytic lobulitis in diagnostic breast biopsies: Clinical, imaging, and pathologic features;Human Pathology;2024-04
5. Multifunctional ZnO@DOX/ICG-LMHP Nanoparticles for Synergistic Multimodal Antitumor Activity;Journal of Functional Biomaterials;2024-01-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3